Keywords
Immune-related adverse events, cancer, immune checkpoint inhibitors, immunotherapy
Abstract
We describe a rare case of polyserositis with chylous ascites following nivolumab therapy, highlighting the challenges in recognizing and managing immune-related adverse events (irAEs) associated with immune checkpoint inhibitors (ICPIs).
References
Views: 105
HTML downloads: 19
PDF downloads: 64
Published:
2024-05-31
Issue:
2024: LATEST ONLINE
(view)